Subscribe to the newsletterForward | Contact |   January 2014
01/06/2014 - In 2014, set your sights on new projects with Lyonbiopole

Lyonbiopole's team wishes you a 2014 prosperous new year !

Learn more

02/11/2014 - Take part in the Take Control Tour 2014 at Accinov

Accinov invites you to take part in the Take Control Tour organized by Pall Life Sciences to be held on February, the 11th. This event is held on a half-day period (attendees choose a morning or afternoon session) and will take place in the modular bioproduction units of Accinov. For further information and registration contacts Take Control Tour – Pall Life Sciences here.

Learn more


ERYTECH Pharma, French biopharmaceutical company, develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs. ERYTECH Pharma
provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors. Having already successfully completed a Phase 1 study in late stage pancreas cancer, in which the tolerability of ERYASP has been confirmed in th is very fragile patient population, ERYTECH has decided to continue the development in sol id tumors by performing a Phase Il study in second line pancreas cancer.

Learn more

02/07/2014 - Call for innovative technological offers R&D or collaborative projects ideas

Gain in visibility by proposing your innovative technological offer or collaborative projects idea before Friday 7th, February 2014 at 5:00 p.m. on line. Selected proposals will be presented during the 2014 CASyM Academic/Industry interaction workshop which takes place in Lyon (FRANCE) on April 10th 2014.
CASyM (Coordinating Action Systems Medicine) is a European project, supported by the FP7- Directorate-General for Research and Innovation of the European Commission, to develop a road map outlining an integrative strategy for the implementation of systems medicine across Europe. This roadmap is used by the European Commission to help define the calls of its Horizon 2020 program.
Contact: Estelle VINCENT, Project Manager

02/11/2014 - Role of modeling and data analysis in healthcare products development meeting

On February 11th 2014, INRIA, in partnership with Lyonbiopole, organizes in Lyon an INRIA-Industry meeting, dedicated to the role of modeling and data analysis and management in the conception of new drugs and healthcare products. Speakers from industry, academia and healthcare professionals will share their experience and provide an overview. Demos from INRIA teams and other Lyonbiopole members will be on display in the showroom. Bioinformatics, "omics" data analysis, bio-modeling, HPC and Big-Data will be among the addressed topics.
Contact: Claudia Chagneau, R&D Projects Manager -

Learn more

03/10-12/2014 - Participate to BIO-Europe Spring Convention 2014 in Turino

Lyonbiopole organises with Rhone Alpes regional council support and its European BioXclusters support a delegation of company during BIO-Europe Spring 2014, from the 10th to the 12th of March, with a special offer to facilitate SMB's members access to such major event. Organized by EDB Cluster, BIO-Europe Spring is a major European Biotechnology partnering convention.
Contact: Simon GUDIN, SMEs’ Development Project Manager -

Learn more

03/25-26/2014 - Go to PDA Europe: Modern Biopharmaceutical Manufacturing

The 2014 European Congress of the Parenteral Drug Association (PDA) will be held on 25 and 26 March 2014 at the Sofitel Lyon Bellecour.
Accinov, the innovation platform of Lyonbiopole will present its innovative model for biomanufacturing in a flexible multi-user and multi-product facility.
Contact: Sylvain Peyrache, Accinov -

Learn more

04/28-05/02/2014 - Participate to the Collective mission to Boston during Bio-IT

Lyonbiopole is pleased to invite you to participate to the collective mission organised with the French health and ICT clusters to be held from April 28th to May 2nd, 2014 in Boston during the Bio-IT convention. This mission is between Health / Engineering Sciences around e-health/ICT topics and will be organized on the occasion of the Bio-IT International Convention in Boston. The mission, programme will be split into 2 key moments: access to Bio-IT convention in Boston (April 29th/ May 1st, 2014), appointment collective or semi-collective Key Accounts: R&D centers, industry in the Boston area (April 28th and May 2nd, 2014).
Contact: Kevin Romani, SMEs’ Development Director -

Learn more

06/5-6/2014 - Save the date : 9th  BIOVISION edition

BIOVISION, the World Life Sciences Forum, in Lyon will be held from 5th to 6th June 2014 in Lyon. BIOVISION will be organized around several key points :
  • An opening plenary session on the theme of "Disruptive Innovation"
  • Two plenary prospective sessions around the focuses "Vaccination for all" and "Healthy ageing"
  • Two Catalyzer sessions, allowing innovative collaborative projects selected to benefit from visibility and meet potential public-private partners.
  • Investor Conference, a high-level investor conference allows selected biotech, medtech and e-health start-up companies to present and to meet the health sector decision-makers and potential public and private investors.
Contact: Kevin Romani, SMEs’ Development Director -

Learn more

Bio-Europe Spring 2014
March 10th to 12 th 2014 -Turino, Italia
Bio-IT World Conference & Expo'14
April 29th to may 1st 2014 - Boston, US
The 16th Shanghai International Forum on Biotechnology and Pharmaceutical Industry
May 21th to 23th 2014 - Shanghai, China
June 5th and 6th 2014 - Lyon, France
BIO 2014
June 23th to 26th 2014 - San Diego, US
12/11/2013 - Publication of the 1st Horizon 2020 calls for projects

The European Commission has published on December 11th 2013 the first Horizon 2020 calls for projects, the new European funding program for research and innovation with a budget of €80 billion, of which more than 15 billion euros for the first two years. The program has three pillars: scientific excellence, nearly 3 billion euros planned, including 1.7 billion for grants for top researchers; industrial leadership: € 1.8 billion are provided to support the industrial leadership of Europe in areas such as biotechnology, nanotechnology, and the societal challenges: € 2.8 billion is dedicated for innovative projects on the 7 social issues including H2020 health. Find all calls on the official portal.
Lyonbiopole supports you for EU project set-up thanks to its ETP programme.
Contact: Emilie Romeo - Europe Project Manager -

Learn more

10/2013 - New Eurostars 2 call for projects

After the success of the 1st Eurostars programme, the EC launches Eurostars 2. This funding programme is fully dedicated to innovative SMEs aiming to launch R&D projects closed to the market, that are collaborative and European (at least 2 partners from EU). The funding rate for projects goes from 30 to 40% (subsidy managed by BPI France). Thus the new Eurostars 2 call for project is launched, which submission deadline is planned on March 13, 2014. Lyonbiopole supports you for EU project set-up thanks to its ETP programme.
Contact: Emilie Romeo - Europe Project Manager -

Learn more

01/2014 – 11th call for projects IMI open

The 11th call for projects open. It covers several major research themes cut into 8 topics around the effective use of biomarkers and biobanks for personalized medicine, preparation and prevention of zoonoses, prevention of Alzheimer's disease (filing date: 04/08/2014). Several webinars are organized.
Lyonbiopole supports you for EU project set-up thanks to its ETP programme.
Contact: Emilie Romeo - Europe Project Manager -

Learn more

01/2014 - ERA -NET calls for European projects

The French National Research Agency is involved in several ERA -NET European funding programs to support research projects in domains as infectious diseases (INFECT-ERA) and antimicrobial resistance (JPI AMR). Two calls for proposals are currently open in this context. INFECT-ERA, the call for proposals is open until 04/02/2014 - find all the information and conditions here and find partners there. JPI in AMR, the first call has been published InnovaResistance: Innovative Approaches to address antibacterial resistance (deadline 03/14/2014). Find all the information here and find partners there. The ANR is involved in other ERA-NETs like EuroNanoMed II (nano-medecine), JPND (neurodegenerative diseases), E-RARE 2 (rare disease). SME participation is strongly encouraged in these programs that are an effective way to integrate a long-term network of European players.
Contact: Emilie ROMEO, Europe Project Manager -

Learn more

01/2014 - Innovation 2030 Worldwide Innovation Challenge

The Innovation 2030 Commission, chaired by Anne Lauvergeon has defined 7 major ambitions relying on strong, growing, societal expectations, for which innovative solutions are needed. Among these pillars for France's future development is Personalised medicine. The Innovation 2030 Worldwide Innovation Challenge will include 3 phases. The Start-up Phase is opened and will end when 100 innovative projects will be selected. The expected projects must be supported by individual company or consortia. The selected projects must show a strong potential for French economy and correspond to one of the seven goals. The selected project receive a financial subsidy which can reach 200 000€.
Contact: Claudia Chagneau, R&D Projects Manager -

Learn more

01/24/2014 - Microvax in the spotlight

On January 24th, during the National Day of Competitiveness Clusters, representatives of Sanofi Pasteur and Becton Dickinson showed  Microvax syringe, a new system of administration of vaccines by intradermal microinjection to ministers Arnaud Montebourg, Fleur Pellerin and Geneviève Fioraso. The aim of this innovative exhibition of 20 objects from collaborative R&D Competitiveness Cluster projects, was to demonstrate concretely the firms innovation efforts in our daily lives. Microvax is a FUI project that was accredited by Lyonbiopole in 2006.

01/22/2014 - HIFI Blood 96 solution has received CE-IVD mark accreditation

HIFI Blood 96™ is the first CE-IVD marked blood genotyping solution on the market that offers full automation and high-throughput.

Learn more

01/21/2014 - First fundraising EUR 610,000

The aim of this initial round of funding is to speed up the development of toll manufacturing services for membrane proteins for use by R&D departments in the pharmaceutical and biotechnology industries.

Learn more

01/15/2014 - Extension in Finland and Spain of its Phase IIb study in Acute Myeloid Leukemia

The study was first launched in France in March 2013. The opening of centers in additional countries is adding international credibility and visibility to the study and is expected to further accelerate the pace of patient recruitment.

Learn more

01/13/2014 - Two new patents in Japan and the United States

Adocia strengthens its diabetic foot ulcer patent portfolio, BioChaperone®.

Learn more

01/06/2014 - K-Plan obtains a loan of € 500,000 from the State

This loan to indrustrialisation of research and development should enable K-Plan to make the necessary investments to play a leading role in the area of field biology and humanitarian action.

16 to 20/12/2013 – Chinese market exploration mission

A delegation of iDD Biotech representative was hosted by Simon Gudin, Lyonbiopole’s representative in Shanghai, and ERAI from the 16th to the 20th of December 2013 at the same time as the 3rd Sino-French cancer’s Symposium organized by CLARA. This mission aimed to explore potential partnership and co-development opportunity with Chinese Biotech. Mission Completed.

Learn more

© Lyonbiopole 2019  |  CREDITS  |  LEGAL NOTICE  |